Loading...
Controversies in Neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease
BACKGROUND: Early initiation of pharmacotherapy in Parkinson's disease (PD) is nowadays widely advocated by experts since the delay of treatment has shown to be associated with a significant deterioration of health related quality of life in affected patients. Due to marked advances in PD treat...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3192665/ https://ncbi.nlm.nih.gov/pubmed/21939547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-11-112 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|